NCT00452842View on ClinicalTrials.gov

Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies

TerminatedOBSERVATIONAL
Enrollment

26,784

Participants

Timeline

Start Date

October 31, 2007

Conditions
Cardiovascular DiseaseCerebrovascular Disorders
Trial Locations (1)

33756

Pfizer Investigational Site, Clearwater

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00452842 - Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies | Biotech Hunter | Biotech Hunter